Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

III. Medizinische Klinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10


Schreiber, J.; Korn, S.

Biologicals in severe asthma. Which antibody is for who?

PNEUMOLOGE. Bd. 14. H. 5. 2017 S. 296-302


Krug, Norbert; Hohlfeld, Jens M.; Buhl, Roland et al.

Blood eosinophils predict therapeutic effects of a GATA3-specific DNAzyme in asthma patients

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Bd. 140. H. 2. 2017 S. 625-+


Weber, Alexander N. R.; Bittner, Zsofia; Liu, Xiao et al.

Bruton's Tyrosine Kinase: An Emerging Key Player in Innate Immunity

FRONTIERS IN IMMUNOLOGY. Bd. 8. 2017


Bousquet, Jean; Brusselle, Guy; Buhl, Roland et al.

Care pathways for the selection of a biologic in severe asthma

EUROPEAN RESPIRATORY JOURNAL. Bd. 50. H. 6. 2017


Fischer, Jeannette; Paret, Claudia; El Malki, Khalifa et al.

CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis

JOURNAL OF IMMUNOTHERAPY. Bd. 40. H. 5. 2017 S. 187-195



Hess, Georg

Checkpoint Inhibition in Non-Hodgkin's Lymphoma

ONCOLOGY RESEARCH AND TREATMENT. Bd. 40. H. 11. 2017 S. 662-672


Rausch, Johanna; Lopez, Pamela Aranda; Bialojan, Ariane et al.

Combined immunotherapy: CTLA-4 blockade potentiates anti-tumor response induced by transcutaneous immunization

JOURNAL OF DERMATOLOGICAL SCIENCE. Bd. 87. H. 3. 2017 S. 300-306


Breitenbuecher, Frank; von Pawel, Joachim; Sebastian, Martin et al.

Comprehensive Biomarker Analyses in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Prospectively Treated with the Polo-Like Kinase 1 Inhibitor BI2536

ONCOLOGY RESEARCH AND TREATMENT. Bd. 40. H. 7-8. 2017 S. 435-439